Research

Rice lab synthesizes cancer-killing compound

Chemist K.C. Nicolaou and team achieve first total synthesis of shishijimicin A


By Mike Williams | July 13, 2015

Rice University scientists have achieved the total synthesis of a scarce natural marine product that may become a powerful cancer-fighting agent – the molecule shishijimicin A.

A group led by world-renowned Rice chemist K.C. Nicolaou announced the successful synthesis this month in the Journal of the American Chemical Society.

The complex organic molecule was discovered in a rare sea squirt, Didemnum proliferum, more than a decade ago. Lab tests at the time proved it to be more than 1,000 times as toxic to cancer cells as the anticancer drug taxol (aka paclitaxel), but its scarcity did not provide amounts sufficient for extensive biological studies and clinical trials.

For that, chemists needed to design and develop the many steps required to synthesize the molecule, a specialty for which Nicolaou is well-known. Nicolaou, who joined Rice in 2013, is noted for achieving the first synthesis of taxol as well as the synthesis of the highly cytotoxic compound calicheamicin, which was used in the first antibody-drug conjugate (ADC) for targeted chemotherapy.

Nicolaou said shishijimicin shows just as much potential – and perhaps more – for cancer treatment via “Trojan horse”-style ADCs tuned to target specific types of cancer. “Because it’s so potent, you may only need one or two molecules to get into a cancer cell to do the job,” he said.

Such toxins kill cancer cells by cleaving their DNA or freezing their cytoskeletons to prevent them from replicating, he said.

The path to synthesis took a rapid two years because much of the groundwork had already been set by Nicolaou’s basic work three decades ago in the total synthesis of calicheamicin.

“All the fundamental science for the shishijimicin project was done in the 1990s,” he said. “What we synthesized then was too toxic to be used, but now it has revitalized the whole field because biologists and clinicians can selectively target cancer cells (with ADCs). If we hadn’t done the fundamental science so many years ago, it would have taken us so much longer to come to the same point.”

Nicolaou said his prime concern, in addition to facilitating biology and medicine, is to advance the field of synthetic chemistry. “If we don’t advance it now, we won’t be able to make the complex molecules of the future,” he said. “We have to continue to sharpen the tools of organic synthesis.”

Nicolaou said the next steps for shishijimicin are to streamline its synthesis and add chemical handles so it can be attached to antibodies for delivery to cancer cells. “We’ve established the beachhead with the first total synthesis,” he said. “Now we aim to optimize the process to make it more practical and apply it to synthesize variations of the molecule.”

Then it will be up to partner pharmaceutical companies to develop the compound for eventual clinical trials. They won’t need much, Nicolaou said. “If they have a few hundred milligrams – a fraction of a gram – they can take it to clinical trials, because it’s so potent,” he said. “And now they have hundreds of antibodies selected for different kinds of cancer. My hope is that our molecule will lead to an effective drug for personalized medicine.”

Rice postdoctoral researchers Zhaoyong Lu, James Woods and Te-ik Sohn and graduate student Ruofan Li are co-authors of the paper. Nicolaou is Rice’s Harry C. and Olga K. Wiess Professor of Chemistry.

The Cancer Prevention and Research Institute of Texas and the Welch Foundation supported the research.




Social Posts

profile_image

TAMU Health Sciences

@TAMHSC

#TAMHSC study suggests #birthcontrol pills may increase risk of seizures: https://t.co/l6WlhCxPRU #TAMUHealth #Epilepsy #Health

8 mins ago
profile_image

Texas Children's

@TexasChildrens

Today on the blog, we're helping parents and caregivers with what to expect when considering psychotherapy for their child: https://t.co/gPetfl1WtW

14 mins ago
profile_image

BCMHouston

@bcmhouston

A novel therapy for pediatric brain tumors could have a lesser impact on the cognitive functioning of children. https://t.co/R4U0Mk5pkv

15 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Our @MariaPetzel: “When assembling a team to tackle your #pancreaticcancer, a dietitian should be one of your first recruits.” https://t.co/bFRKTUr6P0 #pancsm #endcancer https://t.co/Ha3cz5Uvi9

23 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Cancer treatment’s effect on eye health and how we limit it from our @DrSapnaPatel and Dr. Dan Gombos: https://t.co/3gzqaRZ98a @cure_magazine #endcancer

39 mins ago
profile_image

University of Houston

@UHouston

RT @HoustoniaMag: The National Center for Airborne Laser Mapping at @UHouston is revolutionizing archaeology. https://t.co/tepHaQ5xbc https…

39 mins ago
profile_image

Rice University

@RiceUniversity

In a discovery that points to potential new antibiotic medicines, scientists from Rice and the @UMich have deciphered the workings of a common but little-understood bacterial switch that cuts off protein production before it begins. https://t.co/KcFMEh9qdj https://t.co/2ACGEvS187

46 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Tell your Veteran family members and friends you’re there to listen if they need you. Read about other ways to support and connect with your loved ones during #MentalHealthMonth this May. https://t.co/hCxdFzi394

52 mins ago
profile_image

TAMU Health Sciences

@TAMHSC

Do you experience daily #oraldiscomfort after drinking something cold? Here's what may be causing your aching smile: https://t.co/xARH0IFH24

1 hour ago
profile_image

UTMB Health

UTMB.edu

For those still intersted in donating blood, the mobile blood bank will be set up at the following locations in the coming days: League City Campus: Tuesday from 9 a.m. to 3 p.m. Clear Lake Center (20738 Gulf Freeway, Webster, 77598): Tuesday, May 29 from 8:30 a.m. to 2:30 p.m. For more information about donations, please visit: https://www.mdandersonbloodbank.org.

1 hour ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Melanoma survivor, #immunotherapy clinical trial participant: “One of the reasons I came to MD Anderson was the #CancerMoonshot Program.” #endcancer https://t.co/CmuUcDxe33

1 hour ago
profile_image

MD Anderson Cancer Center

MDAnderson

"The most important preparation I had was the privilege of caring for cancer patients as an MD Anderson faculty member for 20 years," says Dr. Peter WT Pisters, who recently returned to MD Anderson for a new role as our fifth full-time president. #endcancer

2 hours ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

Everything seemed to be going well, until Verna Burton arrived in San Francisco for a new job and found out that the place she had put her security deposit down on was a scam. Out of money and nearly out of hope, Verna searched for resources for Veterans to try to avoid a night on the streets. She came across Swords to Plowshares and made her way to their office two minutes before closing.

2 hours ago
profile_image

Rice University

@RiceUniversity

https://t.co/k330W63m1T

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

#VAPodcast 102: Jennifer MacDonald – Army Veteran, Director of Clinical Innovations and Education, @VeteransHealth Connected Care https://t.co/2cJU5jWCfu via #VAntagePoint

2 hours ago